AKT1 and type 2 diabetes mellitus: The molecular docking analysis data of beta-caryophyllene with the insulin downstream signaling molecules such as IRS-1 cSrc and Akt reveals its ability and further studies are needed to elucidate its complete mechanism of action against type-2 diabetes.